pH Sciences
Pre-clinicalDevelops pH-activated drug delivery technologies to improve therapeutic efficacy and reduce side effects.
Founded
2003
Focus
Drug DeliverySmall Molecules
About
Develops pH-activated drug delivery technologies to improve therapeutic efficacy and reduce side effects.
Funding History
2Total raised: $5.5M
Seed$3MUndisclosedMar 15, 2023
Grant$2.5MNational Institutes of Health (NIH)Sep 15, 2021
Company Info
TypePrivate
Founded2003
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile